Search research articles
Contact Us
Filters
Showing results (121-130 of 401) with videos related to
Page
of 41
Sort By:
Vascular Biology (Bristol, England)
|
December 7, 2020
The cardiac complications of COVID-19: many publications, multiple uncertainties
Abdallah Al-Mohammad, David G Partridge, Graham Fent, et al.
Platelets
|
April 23, 2014
PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact
Heather M Judge, Lisa K Jennings, David J Moliterno, et al.
Cardiovascular Diabetology
|
December 18, 2021
A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control
William A E Parker, Rebecca Sagar, Zeyad Kurdee, et al.
British Journal of Clinical Pharmacology
|
November 11, 2018
Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients
Magnus Åstrand, Carl Amilon, Daniel Röshammar, et al.
Vascular Pharmacology
|
April 15, 2015
Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis
Khalaf F Alsharif, Mark R Thomas, Heather M Judge, et al.
Clinical Pharmacokinetics
|
April 21, 2012
Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studies
Steen E Husted, Robert F Storey, Kevin Bliden, et al.
Journal of the American College of Cardiology
|
September 30, 2017
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Carlo Patrono, Joao Morais, Colin Baigent, et al.
European Heart Journal
|
March 25, 2021
Antithrombotic therapy in diabetes: which, when, and for how long?
Ramzi A Ajjan, Noppadol Kietsiriroje, Lina Badimon, et al.
Molecular & Cellular Proteomics : MCP
|
December 8, 2020
A Proteomics-Based Assessment of Inflammation Signatures in Endotoxemia
Sean A Burnap, Ursula Mayr, Manu Shankar-Hari, et al.
Stroke
|
June 27, 2013
Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials"
Stefan K James, Robert F Storey, Karen S Pieper, et al.
Page
of 41
Search research articles
Search
Showing results (121-130 of 401) with videos related to
Sort By:
Page
of 41
Vascular Biology (Bristol, England)
|
December 7, 2020
The cardiac complications of COVID-19: many publications, multiple uncertainties
Abdallah Al-Mohammad, David G Partridge, Graham Fent, et al.
Platelets
|
April 23, 2014
PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact
Heather M Judge, Lisa K Jennings, David J Moliterno, et al.
Cardiovascular Diabetology
|
December 18, 2021
A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control
William A E Parker, Rebecca Sagar, Zeyad Kurdee, et al.
British Journal of Clinical Pharmacology
|
November 11, 2018
Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients
Magnus Åstrand, Carl Amilon, Daniel Röshammar, et al.
Vascular Pharmacology
|
April 15, 2015
Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis
Khalaf F Alsharif, Mark R Thomas, Heather M Judge, et al.
Clinical Pharmacokinetics
|
April 21, 2012
Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studies
Steen E Husted, Robert F Storey, Kevin Bliden, et al.
Journal of the American College of Cardiology
|
September 30, 2017
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Carlo Patrono, Joao Morais, Colin Baigent, et al.
European Heart Journal
|
March 25, 2021
Antithrombotic therapy in diabetes: which, when, and for how long?
Ramzi A Ajjan, Noppadol Kietsiriroje, Lina Badimon, et al.
Molecular & Cellular Proteomics : MCP
|
December 8, 2020
A Proteomics-Based Assessment of Inflammation Signatures in Endotoxemia
Sean A Burnap, Ursula Mayr, Manu Shankar-Hari, et al.
Stroke
|
June 27, 2013
Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials"
Stefan K James, Robert F Storey, Karen S Pieper, et al.
Page
of 41